This also means more people are exploring medical weight-loss options
With the new HoMEso GHK-Cu Rejuvenation Kit, we wanted to take that story one step further
The ideal provider should take your health history into account and guide you toward a personalized treatment plan
Wegovy To obtain Wegovy, you need to meet these conditions: Who can use Wegovy: adults with a body mass index (BMI) of 27 or higher (overweight) who have at least one weight-related condition like high blood pressure or type 2 diabetes adults with a BMI of 30 or higher (obesity) children ages 12 years and older with a BMI at the 95th percentile or more for their age and sex Wegovy is not recommended if you: have a history of pancreatitis have a history of multiple endocrine neoplasia syndrome type 2 have a personal or family history of medullary thyroid carcinoma have an allergy to semaglutide are pregnant, nursing, or planning to get pregnant Ozempic These are the criteria for getting a prescription for Ozempic: Who can use Ozempic: adults with type 2 diabetes without heart disease adults with type 2 diabetes with a risk of heart disease adults with obesity, with or without type 2 diabetes Ozempic is not recommended if: any of the same situations noted for Wegovy also apply you are under the age of 18 years Rybelsus Here are the criteria for getting Rybelsus: Who can use Rybelsus: adults with type 2 diabetes adults with obesity, with or without type 2 diabetes Rybelsus is not recommended if: any of the same situations noted for Wegovy also apply If you need help covering the cost of medications, the free Optum Perks Discount Card could help you save up to 80% on prescription drugs
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
This has elegantly been shown recently in mice via the use of 13 C-labelled fructose (Reference Jang, Hui and Lu8)
